To our experts, can you comment on the study significance in terms of the design for this trial (prospective, randomized, double-blind, parallel arm trial in conjunction with standardized asthma controller therapy) and how it improves over previous studies regarding acetominophen use in asthma?
Q&A has ended
Wanda Phipatanakul, MD, MS
Associate Professor of Pediatrics at Boston Children's Hospital / Harvard Medical School
Ian Paul, MD, MSc
Professor of Pediatrics and Public Health Sciences at Pennsylvania State University College of Medicine
William Sheehan, MD
Instructor of Pediatrics, Harvard Medical School at Boston Children's Hospital
Tzu-Ying Chuang, PhD
MD/PhD candidate at the University of Virginia.
- All Questions & Answers
- Question: Context of the study